The University of Kansas Medical Center, commonly referred to as KU Med or KUMC, is a medical campus for the University of Kansas. KU Med houses the university's schools of medicine, nursing, and health professions, with the primary health science campus in Kansas City, Kansas.

During the past decade, University of Kansas Medical Center conducted 742 clinical trials. In the 10-year time frame, 742 clinical trials started and 358 clinical trials were completed, i.e. on average, 48.2% percent of trials that started reached the finish line to date. In the past 5 years, 360 clinical trials started and 214 clinical trials were completed. i.e. 59.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Kansas Medical Center" #1 sponsor was "University of Kansas Medical Center" with 232 trials, followed by "SWOG Cancer Research Network" with 55 trials sponsored, "University of Kansas" with 35 trials sponsored, "Abbott Medical Devices" with 25 trials sponsored and "Hoffmann-La Roche" with 25 trials sponsored. Other sponsors include 958 different institutions and companies that sponsored additional 516 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Kansas Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 107 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 32 trials as a collaborator, "National Institute on Aging (NIA)" with 25 trials as a collaborator, "University of Kansas Medical Center" with 25 trials as a collaborator and "National Institutes of Health (NIH)" with 22 trials as a collaborator. Other collaborators include 896 different institutions and companies that were collaborators in the rest 477 trials.

According to Clinical.Site data, the most researched conditions in "University of Kansas Medical Center" are "Breast Cancer" (38 trials), "Cystic Fibrosis" (34 trials), "Amyotrophic Lateral Sclerosis" (28 trials), "Pulmonary Arterial Hypertension" (26 trials) and "Multiple Sclerosis" (21 trials). Many other conditions were trialed in "University of Kansas Medical Center" in a lesser frequency.

Most popular intervention types in "University of Kansas Medical Center" are "Drug" (793 trials), "Other" (191 trials), "Device" (154 trials), "Behavioral" (111 trials) and "Biological" (73 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (250 trials), "placebo" (26 trials), "cisplatin" (19 trials), "cyclophosphamide" (18 trials) and "etoposide" (18 trials). Other intervention names were less common.

The vast majority of trials in "University of Kansas Medical Center" are 1171 trials for "All" genders, 109 trials for "Female" genders and 50 trials for "Male" genders.

Currently, there are 355 active trials in "University of Kansas Medical Center". 7 are not yet recruiting, 216 are recruiting, 118 are Active, not recruiting, and 14 are Enrolling by invitation. In total, there were 745 completed trials in University of Kansas Medical Center, undefined suspended trials, and 152 terminated clinical trials to date.

Out of the total trials that were conducted in University of Kansas Medical Center, 91 "Phase 1" clinical trials were conducted, 359 "Phase 2" clinical trials and 352 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 60 trials, and there were also 296 trials that are defined as “Not Applicable".

University of Kansas Medical Center has several departments that took part in Clinical trials: "University of Kansas Medical Center, Department of Neurology" - 11 trials, "University of Kansas Medical Center, Landon Center on Aging" - 6 trials, "University of Kansas Alzheimer's Disease Center" - 5 trials, "University of Kansas School of Nursing" - 3 trials, "Division of Gastroenterology and Hepatology at KUMC" - 2 trials, "University of Kansas; Department of Otolaryngology Head & Neck Surgery" - 2 trials, "University of Kansas Medical Center - Parkinson's Disease Center" - 2 trials, "University of Kansas Med Ctr; Int med/Allgy/Immun/Rheum" - 2 trials, "KU Clinical Research Center - Clinical and Translational Science Unit (CTSU)" - 2 trials